Meredith Brown

Meredith Brown is CEO and president of Twister Biotech, a biotech that makes MiniVectors™ - small, circular, supercoiled DNA constructs that are easily delivered for safer, more effective gene and cell therapies. MiniVectors can be used to replace viral and non-viral vectors, RNAi and protein therapies, or for DNA vaccines.

Prior to running Twister Biotech, Meredith worked for a venture capital office, AlphaDev (now Fannin Innovation), founded a genetic diagnostic firm, and consulted in the areas of corporate strategy development, industry research, business investment, and science and technology evaluation. She received her MBA from University of Texas, Austin and her BA in Biological Sciences from University of California, Santa Barbara.